171 related articles for article (PubMed ID: 10987291)
1. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy.
Nutt CL; Noble M; Chambers AF; Cairncross JG
Cancer Res; 2000 Sep; 60(17):4812-8. PubMed ID: 10987291
[TBL] [Abstract][Full Text] [Related]
2. O(6)-methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes.
Nutt CL; Loktionova NA; Pegg AE; Chambers AF; Cairncross JG
Carcinogenesis; 1999 Dec; 20(12):2361-5. PubMed ID: 10590234
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
[TBL] [Abstract][Full Text] [Related]
4. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.
Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL
Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
Liu L; Schwartz S; Davis BM; Gerson SL
Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
[TBL] [Abstract][Full Text] [Related]
6. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
7. O6-methylguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage.
Nutt CL; Costello JF; Bambrick LL; Yarosh DB; Swinnen LJ; Chambers AF; Cairncross JG
Can J Neurol Sci; 1995 May; 22(2):111-5. PubMed ID: 7627911
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.
Cai S; Xu Y; Cooper RJ; Ferkowicz MJ; Hartwell JR; Pollok KE; Kelley MR
Cancer Res; 2005 Apr; 65(8):3319-27. PubMed ID: 15833865
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression.
Bandres E; Andion E; Escalada A; Honorato B; Catalan V; Cubedo E; Cordeu L; Garcia F; Zarate R; Zabalegui N; Garcia-Foncillas J
J Neurooncol; 2005 Jul; 73(3):189-98. PubMed ID: 15980968
[TBL] [Abstract][Full Text] [Related]
10. Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Davis BM; Reese JS; Koç ON; Lee K; Schupp JE; Gerson SL
Cancer Res; 1997 Nov; 57(22):5093-9. PubMed ID: 9371508
[TBL] [Abstract][Full Text] [Related]
11. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
Marathi UK; Dolan ME; Erickson LC
Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
[TBL] [Abstract][Full Text] [Related]
12. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
13. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.
Koç ON; Reese JS; Davis BM; Liu L; Majczenko KJ; Gerson SL
Hum Gene Ther; 1999 Apr; 10(6):1021-30. PubMed ID: 10223735
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma.
Bacolod MD; Johnson SP; Ali-Osman F; Modrich P; Bullock NS; Colvin OM; Bigner DD; Friedman HS
Mol Cancer Ther; 2002 Jul; 1(9):727-36. PubMed ID: 12479369
[TBL] [Abstract][Full Text] [Related]
15. In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.
Fruehauf JP; Brem H; Brem S; Sloan A; Barger G; Huang W; Parker R
Clin Cancer Res; 2006 Aug; 12(15):4523-32. PubMed ID: 16899598
[TBL] [Abstract][Full Text] [Related]
16. Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.
Marathi UK; Kroes RA; Dolan ME; Erickson LC
Cancer Res; 1993 Sep; 53(18):4281-6. PubMed ID: 8364924
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysis.
Anda T; Shabani HK; Tsunoda K; Tokunaga Y; Kaminogo M; Shibata S; Hayashi T; Iseki M
Neurol Res; 2003 Apr; 25(3):241-8. PubMed ID: 12739231
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of BCNU antitumor efficacy by 9-substituted O6-benzylguanines. Effect of metabolism.
Kokkinakis DM; Moschel RC; Pegg AE; Schold SC
Cancer Chemother Pharmacol; 2000; 45(1):69-77. PubMed ID: 10647505
[TBL] [Abstract][Full Text] [Related]
19. Glial cell-specific differences in repair of O6-methylguanine.
LeDoux SP; Williams BA; Hollensworth BS; Shen C; Thomale J; Rajewsky MF; Brent TP; Wilson GL
Cancer Res; 1996 Dec; 56(24):5615-9. PubMed ID: 8971165
[TBL] [Abstract][Full Text] [Related]
20. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]